Clinical Trial Update: Multiple Ascending Dose Study of BMS-754807 in Patients With Solid Tumors in Japan [Phase 1]

View source ↗

Summary

A Phase 1 multiple ascending dose study of BMS-754807 in patients with solid tumors in Japan was completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• BMS-754807 (BMS-754807)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Neoplasms | Phase 1 | Status: COMPLETED